Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127694772 | 12769477 | 2 | F | 20160908 | 20160923 | 20160921 | 20160927 | EXP | IT-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2016-BI-61668IT | BOEHRINGER INGELHEIM | 72.04 | YR | M | Y | 0.00000 | 20160928 | PH | IT | IT |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127694772 | 12769477 | 1 | PS | MIRAPEXIN | PRAMIPEXOLE | 1 | Oral | STRENGTH 2.1 MG | U | 20667 | PROLONGED-RELEASE TABLET | QD | |||||||
| 127694772 | 12769477 | 2 | SS | MIRAPEXIN | PRAMIPEXOLE | 1 | Oral | 1.05 MG | U | 20667 | 1.05 | MG | PROLONGED-RELEASE TABLET | QD | |||||
| 127694772 | 12769477 | 3 | SS | SINEMET | CARBIDOPALEVODOPA | 1 | Oral | STRENGTH: 100 MG + 25 MG; FORMULATION: EXTENDED RELEASE TABLETS | U | 0 | |||||||||
| 127694772 | 12769477 | 4 | SS | SINEMET | CARBIDOPALEVODOPA | 1 | Oral | STRENGTH: 100MG + 25MG | U | 0 | |||||||||
| 127694772 | 12769477 | 5 | C | XADAGO | SAFINAMIDE | 1 | Unknown | 0 | |||||||||||
| 127694772 | 12769477 | 6 | C | LANSOX | LANSOPRAZOLE | 1 | Unknown | 0 | |||||||||||
| 127694772 | 12769477 | 7 | C | LYRICA | PREGABALIN | 1 | Unknown | STRENGTH: 25 MG | 0 | CAPSULE, HARD | |||||||||
| 127694772 | 12769477 | 8 | C | VOLTAREN | DICLOFENAC SODIUM | 1 | Unknown | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127694772 | 12769477 | 1 | Parkinson's disease |
| 127694772 | 12769477 | 3 | Parkinson's disease |
| 127694772 | 12769477 | 5 | Product used for unknown indication |
| 127694772 | 12769477 | 6 | Product used for unknown indication |
| 127694772 | 12769477 | 7 | Product used for unknown indication |
| 127694772 | 12769477 | 8 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127694772 | 12769477 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127694772 | 12769477 | Abnormal behaviour | |
| 127694772 | 12769477 | Dyskinesia | |
| 127694772 | 12769477 | Irritability | |
| 127694772 | 12769477 | Oedema peripheral |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 127694772 | 12769477 | 1 | 20150101 | 20160909 | 0 | |
| 127694772 | 12769477 | 3 | 20150101 | 20160909 | 0 |